Impact Therapeutics, Inc. (7630)
Market Closed
24 Aug, 08:00 AM
HKEX HKEX Primary 13. 52
HKD +0.06
+0.4458%
- Market Cap
- P/E Ratio
- Div Yield
505,521 Volume
- Eps
13.46 HKD
Previous Close Want to track 7630 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Impact Therapeutics, Inc. (7630) Statistics
Valuation metrics
Market Cap -
Enterprise value 246.29M
Trailing P/E (ttm) -10.05
Forward P/E -
PEG ratio -0.1
Price/Sales (ttm) 21.38
Price/Book (mrq) 3.28
Enterprise Value/Revenue 14.37
Enterprise Value/EBITDA -8.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.93M
Average volume (90 days) 3.78M
Price summary
52-Week low 10.31
52-Week high 47.98
Beta -
50-Day moving average 13.53
200-Day moving average 22.01
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.14%
Operating margin -1.74%
Operational effectiveness
Return on assets -0.22%
Return on equity 3.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.56
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.06%
Book value per share (mrq) 0.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
